251 related articles for article (PubMed ID: 30544177)
1. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
[TBL] [Abstract][Full Text] [Related]
2. KRAS/BRAF mutations in brain arteriovenous malformations: A systematic review and meta-analysis.
Bameri O; Salarzaei M; Parooie F
Interv Neuroradiol; 2021 Aug; 27(4):539-546. PubMed ID: 33401991
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in intracranial arteriovenous malformations.
Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
[TBL] [Abstract][Full Text] [Related]
4. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
5. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations.
El Sissy FN; Wassef M; Faucon B; Salvan D; Nadaud S; Coulet F; Adle-Biassette H; Soubrier F; Bisdorff A; Eyries M
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):905-912. PubMed ID: 35238086
[TBL] [Abstract][Full Text] [Related]
7. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
[TBL] [Abstract][Full Text] [Related]
8. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
9. Arteriovenous malformation phenotype resembling congenital hemangioma contains KRAS mutations.
Sudduth CL; McGuire AM; Smits PJ; Konczyk DJ; Al-Ibraheemi A; Fishman SJ; Greene AK
Clin Genet; 2020 Dec; 98(6):595-597. PubMed ID: 32799314
[TBL] [Abstract][Full Text] [Related]
10. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Fish JE; Radovanovic I
N Engl J Med; 2018 Apr; 378(16):1561-1562. PubMed ID: 29669234
[No Abstract] [Full Text] [Related]
11. Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer.
Nicoś M; Krawczyk P; Jarosz B; Sawicki M; Szumiłło J; Trojanowski T; Milanowski J
Clin Exp Med; 2016 May; 16(2):169-76. PubMed ID: 25902737
[TBL] [Abstract][Full Text] [Related]
12. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
Bennani B; Gilles S; Fina F; Nanni I; Ibrahimi SA; Riffi AA; Nejjari C; Benajeh DA; El Abkari M; Martin PM; Ouafik L
Int J Biol Markers; 2010; 25(4):179-84. PubMed ID: 21161938
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
16. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.
Bhaumik S; Ahmad F; Das BR
Med Oncol; 2016 Oct; 33(10):117. PubMed ID: 27637917
[TBL] [Abstract][Full Text] [Related]
20. Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits.
Ma W; Brodie S; Agersborg S; Funari VA; Albitar M
Mol Diagn Ther; 2017 Oct; 21(5):571-579. PubMed ID: 28639239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
